CVS/pharmacy to host Halloween customer appreciation event in stores
WOONSOCKET, R.I. — CVS/pharmacy is holding on Oct. 23 its first annual "2011 Halloween Party and Customer Event" at all 7,200 locations nationwide.
Children who slip on a Halloween costume and purchase any item at any CVS/pharmacy location on Oct. 23 during regular store hours will receive one free Halloween gift pack per child, as well as an in-store costume photo shoot, which includes a free 5×7 print, during select times throughout the day.
The Halloween gift pack, available for free with any purchase while supplies last, includes:
$5 value of candy, toys, trick-or-treat safety items; and
$10 in coupons for additional Halloween products.
In addition, from Oct. 23 to 25, shoppers will find deals on two Halloween must-haves: candy corn and 4-in-1 pumpkin carver kits. ExtraCare cardholders can pick these items up for free after ExtraBucks Rewards.
Living Proof launches Restore to battle dry, damaged hair
CAMBRIDGE, Mass. — Hair care brand Living Proof, which is sold at such retailers as Sephora and Ulta, has launched its latest breakthrough in hair care: Restore.
"Restore really challenges the status-quo. It is a solution that addresses the causes of dryness and damage, offering immediate and long-term benefits, without oils and silicones," Living Proof co-founder and CEO Jon Flint said. "Living Proof aims to solve the toughest beauty problems. We’re not satisfied with offering just a quick fix."
Before hair is ever color-treated, processed or heat-styled, it is virgin hair — strong, smooth, soft, shiny and manageable. Virgin hair has a protective layer that is perfectly intact, which is why it is in such great condition. But everyday routines damage this protective layer, making it highly porous. Therefore, hair is unable to seal in moisture and becomes dull, rough, stiff, brittle and defenseless against damage.
Oils and silicones mask dryness and damage under a heavy coating that weighs hair down. And hair is left feeling greasy and dirty, so you have to wash your hair over and over again. But washing again leads to more brushing and heat styling, so the cycle of dryness and damage continues, the manufacturer stated.
To battle the problem, Living Proof scientists invented Restore, a weightless solution that reduces the porosity of dry or damaged hair to make it look, feel and behave like virgin hair. The shampoo, conditioner and mask treatment are developed with a moisture-controlling molecule, PolyfluoroEster, to create a protective layer. This layer acts like the natural, protective layer on virgin hair and is designed to reduce porosity by 100%. The end result is hair’s porosity is normalized to be like virgin hair. According the manufacturer, Restore also increases the hair’s resistance to breakage by 20 times, while healing, protecting and preventing further damage.
The first step to breaking the cycle of dryness and damage is to use Restore shampoo and conditioner. For more intensive treatment, use Restore mask treatment after first cleansing with Restore shampoo. Restore mask treatment can be used in place of Restore conditioner up to two times weekly, depending on the severity of the hair’s dryness or damage. It is safe for color-treated hair.
Restore will be available at Sephora, QVC, Ulta, Nordstrom and Livingproof.com; $28 for shampoo, $28 for conditioner and $42 for mask treatment.
Abbott to split into two public cos. — medical devices and pharmaceuticals
ABBOTT PARK, Ill. — Abbott on Wednesday morning announced plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.
"Today’s news is a significant event for Abbott, and reflects another dynamic change in our company’s 123-year history, strengthening our outlook for strong and sustainable growth and shareholder returns," Abbott chairman and CEO Miles White said.
The diversified medical products company will consist of Abbott’s existing diversified medical products portfolio, including its branded generic pharmaceuticals, devices, diagnostic and nutritional businesses, and will retain the Abbott name. The diversified medical products company has approximately $22 billion in annual revenue today and a durable mix of products balanced across four major businesses. Abbott will continue to target double-digit ongoing earnings-per-share growth, with opportunities for geographic expansion, particularly in high-growth emerging markets, the company stated.
The research-based pharmaceutical company will include Abbott’s current portfolio of proprietary pharmaceuticals and biologics and will be named later. The company has nearly $18 billion in annual revenue today and will have a sustainable portfolio of market-leading brands, including Humira (adalimumab), Lupron (leuprolide acetate injection), Synagis (palivizumab), Kaletra (lopinavir/ritonavir), Creon (pancrelipase) and Synthroid (levothyroxine). A pipeline of innovative research and development assets in important specialty therapeutic areas, such as Hepatitis C, immunology, chronic kidney disease, women’s health, oncology and neuroscience will help drive future growth, the company stated.
White will remain chairman and CEO of Abbott, the diversified medical products company. Richard Gonzalez, currently EVP global pharmaceuticals, will become chairman and CEO of the research-based pharmaceutical company. Gonzalez is a more than 30-year Abbott veteran and was previously president and COO of Abbott.
The transaction is intended to take the form of a tax-free distribution to Abbott shareholders of a new publicly traded stock for the new pharmaceutical company. The transaction is expected to be completed by the end of next year, but is subject to final approval by the Abbott board of directors, receipt of a favorable ruling from the Internal Revenue Service on the tax-free nature of the transaction, and the effectiveness of a Form 10 registration statement that will be filed with the Securities and Exchange Commission that will include information about the distribution and related matters. Abbott expects to incur one-time charges related to the transaction during the periods preceding the separation, to be quantified at a later date.